Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pritesh J Gandhi

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Thrombosis and Thrombolysis|April 17, 2004
A review of the clinical uses of ximelagatran in thrombosis syndromesElizabeth A Bergsrud, Pritesh J Gandhi
Current Cardiology Reports|June 13, 2003
Emergency management of hemorrhagic complications in the era of glycoprotein IIb/IIIa receptor antagonists, clopidogrel, low molecular weight heparin, and third-generation fibrinolytic agentsWalter S Schroeder, Pritesh J Gandhi
Journal of Thrombosis and Thrombolysis|March 26, 2003
Aspirin resistance and genetic polymorphismsJosie A Cambria-Kiely, Pritesh J Gandhi
Journal of Thrombosis and Thrombolysis|May 8, 2002
Possible mechanisms of aspirin resistanceJosie A Cambria-Kiely, Pritesh J Gandhi
The Annals of Pharmacotherapy|July 29, 2004
CD40 ligand: a novel target in the fight against cardiovascular diseaseDiana Vishnevetsky, Vladimir A Kiyanista, Pritesh J Gandhi
Journal of Thrombosis and Thrombolysis|September 30, 2006
Possible mechanisms of drug-induced aspirin and clopidogrel resistanceWalter S Schroeder, Linda Ghobrial, Pritesh J Gandhi
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 17, 2004
Sirolimus-eluting coronary stentDiana Vishnevetsky, Payal Patel, Hector Tijerino, et al.
Journal of Thrombosis and Thrombolysis|January 24, 2004
Effects of angiotensin converting enzyme inhibitors on thrombotic mediators: potential clinical implicationsSeema A Kothari, Mytrang K Le, Pritesh J Gandhi
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 24, 2009
Lepirudin-induced thrombocytopenia following subcutaneous administrationWalter S Schroeder, Maichi T Tran, Pritesh J Gandhi
Pharmacotherapy|December 9, 2004
Antifactor Xa levels in four patients with burn injuries who received enoxaparin to prevent venous thromboembolismDinesh Yogaratnam, Brian S Smith, Peter B Angood, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Thrombosis and Thrombolysis|April 17, 2004
A review of the clinical uses of ximelagatran in thrombosis syndromesElizabeth A Bergsrud, Pritesh J Gandhi
Current Cardiology Reports|June 13, 2003
Emergency management of hemorrhagic complications in the era of glycoprotein IIb/IIIa receptor antagonists, clopidogrel, low molecular weight heparin, and third-generation fibrinolytic agentsWalter S Schroeder, Pritesh J Gandhi
Journal of Thrombosis and Thrombolysis|March 26, 2003
Aspirin resistance and genetic polymorphismsJosie A Cambria-Kiely, Pritesh J Gandhi
Journal of Thrombosis and Thrombolysis|May 8, 2002
Possible mechanisms of aspirin resistanceJosie A Cambria-Kiely, Pritesh J Gandhi
The Annals of Pharmacotherapy|July 29, 2004
CD40 ligand: a novel target in the fight against cardiovascular diseaseDiana Vishnevetsky, Vladimir A Kiyanista, Pritesh J Gandhi
Journal of Thrombosis and Thrombolysis|September 30, 2006
Possible mechanisms of drug-induced aspirin and clopidogrel resistanceWalter S Schroeder, Linda Ghobrial, Pritesh J Gandhi
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 17, 2004
Sirolimus-eluting coronary stentDiana Vishnevetsky, Payal Patel, Hector Tijerino, et al.
Journal of Thrombosis and Thrombolysis|January 24, 2004
Effects of angiotensin converting enzyme inhibitors on thrombotic mediators: potential clinical implicationsSeema A Kothari, Mytrang K Le, Pritesh J Gandhi
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 24, 2009
Lepirudin-induced thrombocytopenia following subcutaneous administrationWalter S Schroeder, Maichi T Tran, Pritesh J Gandhi
Pharmacotherapy|December 9, 2004
Antifactor Xa levels in four patients with burn injuries who received enoxaparin to prevent venous thromboembolismDinesh Yogaratnam, Brian S Smith, Peter B Angood, et al.
Pageof 3